Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 27;21(1):449.
doi: 10.1186/s12882-020-02112-0.

The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation

Affiliations
Review

The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation

Sam Kant et al. BMC Nephrol. .

Abstract

The pandemic of coronavirus disease 2019 (CoVID-19) has been an unprecedented period. The disease afflicts multiple organ systems, with acute kidney injury (AKI) a major complication in seriously ill patients. The incidence of AKI in patients with CoVID-19 is variable across numerous international studies, but the high incidence of AKI and its associated worse outcomes in the critical care setting are a consistent finding. A multitude of patterns and mechanisms of AKI have been elucidated, and novel strategies to address shortage of renal replacement therapy equipment have been implemented. The disease also has had consequences on longitudinal management of patients with chronic kidney disease and end stage kidney disease. Kidney transplant recipients may be especially susceptible to CoVID-19 as a result of immunosuppression, with preliminary studies demonstrating high mortality rates. Increased surveillance of disease with low threshold for testing and adjustment of immunosuppression regimen during acute periods of illness have been recommended.

Keywords: AKI; CKD; CoVID-19; Disparity; ESKD; Transplantation.

PubMed Disclaimer

Conflict of interest statement

BGJ is a section editor and DCC is an editorial advisor for BMC Nephrology.

References

    1. Arabi YM, Arifi AA, Balkhy HH, Najm H, Aldawood AS, Ghabashi A, et al. Clinical course and Outcomes of Critically Ill Patients With Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014;160(6):389–397. doi: 10.7326/M13-2486. - DOI - PubMed
    1. ALKINDI F, Boobes Y, Nair SC, Hashmey R. SAT-028 ACUTE KIDNEY INJURY ASSOCIATED WITH MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-CoV) INFECTION. Kidney Int Rep. 2020;5:S13. doi: 10.1016/j.ekir.2020.02.033. - DOI
    1. Cha R-H, Joh J-S, Jeong I, Lee JY, Shin H-S, Kim G, et al. Renal complications and their prognosis in Korean Patients with Middle East respiratory syndrome-coronavirus from the central MERS-CoV designated hospital. J Korean Med Sci. 2015;30(12):1807–1814. doi: 10.3346/jkms.2015.30.12.1807. - DOI - PMC - PubMed
    1. Chu KH, Tsang WK, Tang CS, Lam MF, Lai FM, To KF, et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int. 2005;67(2):698–705. doi: 10.1111/j.1523-1755.2005.67130.x. - DOI - PMC - PubMed
    1. Alsolamy S. Middle East respiratory syndrome: knowledge to date. Crit Care Med. 2015;43(6):1283–1290. doi: 10.1097/CCM.0000000000000966. - DOI - PubMed

MeSH terms

Substances